9 Meters Biopharma Past Performance
How has 9 Meters Biopharma performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NMTR is currently unprofitable.
Growing Profit Margin: NMTR is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NMTR is unprofitable, and losses have increased over the past 5 years at a rate of 21.8% per year.
Accelerating Growth: Unable to compare NMTR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NMTR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (7%).
Return on Equity
High ROE: NMTR has a negative Return on Equity (-307.5%), as it is currently unprofitable.